elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28066776-3EBC438C-E058-451D-A7DB-E5C1B030D28B
Q28066776-3EBC438C-E058-451D-A7DB-E5C1B030D28B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28066776-3EBC438C-E058-451D-A7DB-E5C1B030D28B
Experience with biosimilar infliximab (CT-P13) in paediatric patients with inflammatory bowel diseases
P2860
Q28066776-3EBC438C-E058-451D-A7DB-E5C1B030D28B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28066776-3EBC438C-E058-451D-A7DB-E5C1B030D28B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
096ba8b85b52208c13c223de36008c6da0453e32
P2860
Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy.